The 2016 Act covered it before it ever arrived

Short answer: THCP has never been legal to sell in the United Kingdom, and there was never a window in which it was. The Psychoactive Substances Act 2016 bans the supply of any substance capable of producing a psychoactive effect unless it appears on a short list of exemptions, and it does that by definition rather than by name.

That makes Britain unusual. Across the Channel, France spent two years chasing one molecule at a time before classifying seven at once in June 2024. This page explains where THCP came from, what the widely quoted «33 times» figure actually measured, and why the British approach produced a different outcome from the same starting point.

How the 2016 Act works

Four points, and the first explains the rest.

It bans by definition, not by name

The Act prohibits producing, supplying or importing any substance that is capable of producing a psychoactive effect in a person who consumes it. There is no schedule of named molecules to be added to, which is precisely why no new compound has ever found a gap.

The exemptions are the whole schedule

Alcohol, nicotine, caffeine, food and medicinal products are carved out explicitly, and everything outside those carve-outs falls in. It is a list of what is allowed rather than a list of what is forbidden, and that inversion is the entire mechanism.

Possession for personal use sits outside it

The Act targets supply and import rather than simple possession, which is a deliberate design choice and one that distinguishes it from the Misuse of Drugs Act 1971. Selling is the conduct it addresses.

And it was written for exactly this problem

Parliament passed it after years of new compounds appearing faster than they could be scheduled one by one. THCP is a textbook example of the situation it was designed to cover.

Why that matters across Europe

Four consequences, and they are visible in the calendar.

There was no legal vacuum

In most of Europe the molecule circulated for months because nobody had put it on a list — not because anyone had permitted it. In Britain that window never opened.

No substitute closes a gap

Where a country bans one named molecule, a variant with one atom moved appears within weeks. A definitional ban covers the variant before it is synthesised.

Enforcement does not wait for a name

Authorities do not need to prove a compound appears on a schedule, only that it is psychoactive and not exempt. That shifts the burden entirely.

And Croatia reached the same place differently

Croatian law bans whole structural families of compounds, which produced the same outcome by a different route. Two mechanisms, one result: no gap.

Where THCP came from

Four points, and the second is the one advertising distorts.

It was identified in 2019

Italian researchers isolated it from a medical cannabis variety and published their description that year. It is a recent discovery, unlike HHC, which was described in 1944.

It differs from THC in one chain

Structurally it is THC with a side chain of seven carbon atoms instead of five. That apparently minor difference is what changes how it behaves at the receptor.

It occurs in the plant only in traces

It has been detected at concentrations too low to have any practical use. Everything that circulated on the European market was synthesised in a laboratory.

And it reached shops before it was understood

About three years passed between the scientific publication and retail availability. The market did not wait for the literature to fill out.

What «33 times» actually measured

Four points, and this is the most important section on the page.

The measurement was binding affinity

The 2019 study measured, in cells, how strongly the molecule binds to the CB1 receptor, and found a figure around thirty-three times that of THC. Binding affinity describes how tightly a molecule attaches to a receptor in vitro.

Affinity and potency are not the same quantity

A molecule can bind tightly and produce a modest effect, or bind loosely and produce a marked one. Between binding in a dish and an effect in a body sit absorption, distribution, metabolism and elimination.

The number travelled out of its context

What was a pharmacology measurement on cells became a selling point on labels. The figure is accurate; the use made of it is not.

And the study says nothing more

The authors describe an affinity and call for further work. No publication has established a potency ratio in humans, and this page goes no further than the literature allows.

Why these molecules keep arriving

Four stages, and the cycle repeats identically.

One molecule gets scheduled

A substance reaches the market absent from every list, sells for a few months, then gets scheduled after adverse reports. That was HHC’s path between 2022 and 2024.

A variant appears within weeks

One atom moved, one chain lengthened, one group added, and the new molecule is on no list. HHCP, HHCPO and THCP all came from that logic.

The same argument gets reused

«Legal because unscheduled» and «x times stronger» return with each generation, with different numbers. The argument does not depend on the molecule.

And regulators change method

France scheduled seven substances at once and Germany extended its ban to structural analogues in December 2025. Banning a class rather than a compound is the answer to this cycle — which is what Britain had been doing since 2016.

Where Europe stands on THCP

The calendar, country by country.

The trigger was the same everywhere

In every country the scheduling followed months of open sale and reports from emergency or addiction-monitoring services. The order was identical and only the dates differ.

Generic schedules are winning

More states now describe families of compounds rather than named molecules, which is what Croatia and Britain already did. It is the only approach that is not one variant behind.

And the 1971 Convention frames the rest

The UN Commission on Narcotic Drugs listed HHC under the Convention with effect from 6 December 2025, binding every state party. The same mechanism can reach the molecules that follow.

What is actually at risk

Four consequences, and the likeliest is not the gravest.

The parcel is detained

The commonest outcome is not a prosecution but detention at the border. A notice follows, the product never arrives, and the money rarely comes back.

Supply is the offence, not possession

Under the 2016 Act it is producing, supplying and importing that are prohibited, and importing covers ordering from abroad. That distinction is the one most often missed.

The seller is out of reach

Shops still shipping are almost all established outside the United Kingdom. When a parcel is detained, it is the recipient who answers.

And drug tests do not distinguish

Routine screening does not separate these molecules from THC. A positive result therefore carries no useful distinction, independently of the legal question.

How to spot a shop still selling it

Four signals, and the first is nearly always enough.

The product is listed with no country note

A shop operating within the rules states where it ships and where it does not. A product page with no geographic restriction at all belongs to a shop that has not done the work.

The legal pages are stale

A legality section that does not mention the ANSM decision of 3 June 2024, or that presents the Netherlands as an open market, has not been updated in over a year.

There is no batch certificate

A product whose composition was altered in a laboratory, sold without a certificate for the batch, offers no independent verification of its contents.

And the name is a fresh acronym

Every scheduling produces a derivative with one letter changed and the same promise attached. The German analogue clause exists precisely because of that.

What remains lawful, plainly

Four categories, and what separates them is form, not molecule.

Cannabidiol

CBD remains lawful in the United Kingdom and across most of the Union because it is not psychotropic. It is the substance most of this site is about.

Cannabinol

CBN was the one molecule the French decision of 3 June 2024 explicitly left out. That exception is stated in the agency’s own communication.

Industrial hemp products

Oils, cosmetics and foods made from varieties on the official catalogues and below the legal threshold remain marketable, each category under its own regime.

But form outweighs content

Several member states have specifically restricted flower and resin, including below the threshold. That is the most important distinction on this page and the most often ignored.

What the chemistry does not settle

Four limits the marketing worked around.

Synthesis leaves residues

A reaction run without laboratory control leaves by-products that depend on the catalyst and the conditions. Without a batch analysis there is no information about them at all.

The isomers are not equivalent

THCP exists in several isomeric forms whose behaviour differs, and the proportion depends on the process. Almost no product stated it.

Dosing was never standardised

E-liquids and gummies circulated with no fixed unit dose, which is behind most of the reports that reached emergency services. That is a product problem, not a molecule problem.

Purity could not be checked

Without a certificate for the batch there was no way to verify either the stated content or the absence of contaminants, and the buyer had nothing to inspect but the packaging. It is the gravest gap of the whole period and the one that applied to every product in the family.

And declared content often did not match

Independent laboratory testing on products in this family has repeatedly found gaps between the printed figure and the actual content. Without a batch certificate the buyer had no way of noticing.

Why the data are so thin

Four reasons, and they reinforce one another.

The molecule is recent

Described in 2019, it has a literature of a few years, against decades for CBD. What is missing is not interest but time.

Research follows regulation

Studying a controlled substance requires licences that take years, so the ban delays the knowledge that might have grounded it better. The order is inverted and well known.

The reports come from emergency departments

Most of what is known about adverse effects comes from cases recorded in emergency and addiction-monitoring services. Those are real data, and biased by construction.

And the market vanished before the study

With bans across Europe, consumption becomes informal and therefore unobservable. Knowledge about THCP will probably stay frozen where it is.

What to ask before buying any cannabinoid

Four questions with a checkable answer, valid for everything this site covers.

What is the molecule, spelled out

Three- and four-letter acronyms are designed to sound familiar. The full chemical name lets you check which schedule the substance sits on, if any.

Where is the certificate for this batch

Not a supplier certificate in general, but the one for the batch in the packaging, with a matching number. Anyone who cannot show it within a reasonable time is selling goods of unverified composition.

May this product form circulate here

That question is separate from the previous one and has to be asked for the country you are in. A content figure below the threshold does not make a form admissible if the form is restricted.

And who answers if the parcel is detained

The honest answer is that nobody does. If the shop promises a refund or a reshipment, it is worth understanding on what basis.

How two offers compare

Three steps, and the first filters out most comparisons.

Check whether both have a certificate

Without an analysis on both sides there is no comparison, only a conversation about descriptions. It is the step where most comparisons end, and on its own it already says something about both sellers.

Check the batch numbers against the packaging

The number on the document and the number on the pack have to match, or the certificate describes a different batch from the one in your hand. It is the fastest check of all and the one that most often fails with resellers.

And ask which molecule, spelled out

A seller who names the compound in full knows what they are selling; one who answers with an acronym may not. The full name is also what lets you check the schedule yourself.

A short glossary

Four terms that recur on this page.

Binding affinity

How strongly a molecule attaches to a receptor, measured in cells. It is not a measure of effect.

Side chain

The part of the molecule that differs between THC and THCP: five carbon atoms against seven. It is the only structural difference between them.

Isomer

A molecule with the same formula but a different arrangement, whose behaviour can vary. THCP has several.

Definitional ban

A prohibition written around a property — here, psychoactivity — rather than a list of names. It is the mechanism of the 2016 Act.

The most common misreadings

Four mistakes that keep returning.

Reading «33 times» as potency

The figure describes binding affinity measured in cells, not an effect in a body. That is the central confusion of the whole subject.

Assuming unscheduled means permitted

A substance absent from the lists is absent because nobody put it there, not because anyone allowed it. In Britain that reasoning never applied at all.

Thinking possession and supply are the same question

The 2016 Act targets supply and import rather than simple possession, and ordering from abroad is importing. The distinction matters.

And confusing the certificate with legality

An analysis says what is in the product, not whether that form may circulate where you are. Those are two separate questions.

Frequently asked questions

Is THCP legal in the UK

No, and it never was. The Psychoactive Substances Act 2016 prohibits producing, supplying and importing any substance capable of producing a psychoactive effect unless it is on the short list of exemptions, which covers alcohol, nicotine, caffeine, food and medicines. Because the ban works by definition rather than by name, no new compound has ever found a gap.

Is THCP really thirty-three times stronger than THC

That is not what the study measured. The 2019 work measured, in cells, how strongly the molecule binds to the CB1 receptor and found a figure around thirty-three times that of THC. Binding affinity and potency in a body are different quantities, and no publication has established a potency ratio in humans.

Is any cannabinoid in this family still permitted

CBN. It was the one molecule the French decision of 3 June 2024 explicitly left out, and CBD, which is not psychotropic, obviously remains lawful.

What happens if I order from a foreign shop

The law of the country the parcel enters is what applies, not the law of the country it left. Under the 2016 Act importing is one of the prohibited acts, the likeliest outcome is detention at the border, and it is the recipient rather than the seller who answers.